
Efficacy and Tolerance of SGLT2 Inhibitors in Patients with Prader-Willi Syndrome and Type 2 Diabetes
A groundbreaking French study has provided the first comprehensive evidence

A groundbreaking French study has provided the first comprehensive evidence

Researchers have developed a groundbreaking artificial intelligence system called DiabetAid

A comprehensive analysis of over 74,000 patients with type 2

Italian researchers presented compelling evidence today at the 61st European

A comprehensive real-world study presented at the 61st European Association

A comprehensive analysis from the STEP UP trial presented at

A comprehensive analysis from the STEP UP trial presented at

Groundbreaking results presented at the 61st European Association for the

A groundbreaking study presented at the 61st European Association for

The European Association for the Study of Diabetes (EASD) today

Groundbreaking research from Germany has revealed how the human body

Researchers presenting at the 61st Annual Meeting of the European